banner2

Getting started
CAS 14975-30-5

CAS 14975-30-5 - Manufacturers, Factory, Suppliers from China

CAS 14975-30-5, , , ,. The product will supply to all over the world, such as Europe, America, Australia,, ,, .

Related Products

L-Argininamide Dihydrochloride CAS 14975-30-5 Factory Shanghai Ruifu Chemical Co., Ltd. www.ruifuchem.com — L-Argininamide Dihydrochloride CAS 14975-30-5 H-Arg-NH2·2HCl Purity >98.5% (TLC)
Read More

L-Argininamide Dihydrochloride CAS 14975-30-5 H-Arg-NH2·2HCl Purity >98.5% (TLC)

Fmoc-Asp-OtBu CAS 129460-09-9 Assay ≥98.5% (HPLC)

Fmoc-Cys(Dpm)-OH CAS 247595-29-5 Assay ≥98.0% (HPLC)

Fmoc-D-Asn(Trt)-OH CAS 180570-71-2 Assay ≥99.0% (HPLC)

Fmoc-Cys(Mtt)-OH CAS 269067-38-1 Assay ≥98.0% (HPLC)

Fmoc-Dap-OH CAS 181954-34-7 Assay ≥98.0% (HPLC)

banner4

Top Selling Products

Related Blog
Reviews

The “Summit on COVID-19 Diagnostics & Treatment”

The “Summit on COVID-19 Diagnostics & Treatment” September 27-29, 2021 at China International Exhibition Center (Tianzhu New Hall), Beijing. The outbreak of Corona Virus Disease 2019 (...
Xi presents award to top scientists

President Xi Jinping, also general secretary of the Communist Party of China (CPC) Central Committee and chairman of the Central Military Commission, presents China’s top science award to a...
Focus on Cross Border Integration of Biomedicine and Chemical Materials, October 15, 2021

Focus on Cross Border Integration of Biomedicine and Chemical Materials: New Opportunities, New Technologies and New Models This forum focuses on the interdisciplinary and cutting-edge technologies...
The 19th Beijing Conference and Exhibition on Instrumental Analysis (BCEIA 2021)-Shanghai Ruifu Chemical Co., Ltd. participated in the exhibition

The 19th Beijing Conference and Exhibition on Instrumental Analysis (BCEIA 2021) was held on September 27-29, 2021 at China International Exhibition Center (Tianzhu New Hall), Beijing. Adhering to...
Pfizer's Novel COVID-19 Oral Antiviral Treatment Candidate Reduced Risk Of Hospitalization Or Death By 89% In Interim Analysis Of Phase 2/3 EPIC-HR Study

Friday, November 05, 2021 – 06:45am PAXLOVID™ (PF-07321332; ritonavir) was found to reduce the risk of hospitalization or death by 89% compared to placebo in non-hospitalized high-risk adult...
Test Method of (R)-(-)-3-Pyrrolidinol Hydrochloride CAS: 104706-47-0

Eqiupment: GC instrument (Shimadzu GC-2010) Column: DB-17 Agilent 30mX0.53mmX1.0μm Initial oven temperature: 80℃ Initial time 2.0min Rate ...

2022.12.22 10:06:51
2022.11.09 21:05:09
2022.07.24 22:52:04
2022.05.18 17:59:27
2021.12.02 11:19:01
2021.11.29 21:11:56

related search